DefiniGEN appoints Chris Kirton as CEO
Article continues below
Dr. Kirton has more than 16 years of operational experience and joined DefiniGEN as Chief Operating Officer in June 2020.
Dr. Kirton began his operational management career by establishing and growing the Cell Biology and Immunology business unit at a global CRO from a small local team to an international business, offering a full range of GxP services with multi-million-pound revenues.
He then went on to collaborate with Ludovic Vallier to establish the world’s largest stem cell core facility at the Wellcome Trust Sanger Institute, which delivered the HiPSCi iPSC banking project. ■